Pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in cows following single dose intravenous administration

Journal of Veterinary Pharmacology and Therapeutics

Volumn 26, Issue 4, 2003, Pages 303-305

  Varma, R ^a   Ahmad, A H ^a   Sharma, L D ^a   Aggarwal, P ^b   Ahuja, V ^a  

^a G B PANT UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (India)

^b Ranbaxy Animal Health India Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ENROCIN; ENROFLOXACIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; EVALUATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; CATTLE; CIPROFLOXACIN; FEMALE; FLUOROQUINOLONES; INJECTIONS, INTRAVENOUS; QUINOLONES;

ANIMALIA;

EID: 0043162100     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2003.00480.x     Document Type: Article

References (10)

1. Blaser, J., Stone, B.B. & Groner, M.C. (1987) Comparative study with enoxacin and natilmicine in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrobial Agents and Chemotherapy, 31, 1054-1060.
2. Davidson, J.N., Conzelman, G.M. & Baggot, J.D. (1986) Pharmacokinetics of 1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3 quinolone-carboxylic acid (CFPQ) in pre-ruminant and ruminant calves. Proceedings of Western Pharmacological Society, 29, 129-132.
3. Flammer, K., Aucoin, D.P. & Whitt, D.A. (1991) Intramuscular and oral disposition of enrofloxacin in African Gray Parrots following single and multiple doses. Journal of Veterinary Pharmacology and Therapeutics, 14, 359-366.
4. Forrest, A., Nix, D.E., Ballow, C.H., Goss, T.F., Birmingham, M.C. & Schentag, J.J. (1993) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy, 37, 1073-1081.
5. Gibaldi, M. and Perrier, D. (1982) Pharmacokinetics, 2nd edn. Marcel-Dekker, Inc., NY.
6. Küng, K.L., Riond, J.-L. & Wanner, M. (1993) Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. Journal of Veterinary Pharmacology and Therepeutics, 16, 462-468.
7. Kaartinen, L., Pyörälä, S., Moilanen, M. & Räisänen, S. (1997) Pharmacokinetics of enrofloxacin in new born and one week old calves. Journal of Veterinary Pharmacology and Therapeutics. 20, 470-482.
8. Malbe, M., Salonen, M., Fang, W., Oopik, T., Jalakas, M., Klaassen, M. & Sandholm, M. (1996) Disposition of enrofloxacin (Baytril)™ into the udder after intravenous and intra-arterial injections into dairy cows. Journal of Veterinary Medicine, A43, 377-386.
9. Nielsen, P. & Hansen, N.G. (1997) Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. Pharmacology and Toxicology, 80, 246-250.
10. Prescott, J.F. & Yielding, K.M. (1990) In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Canadian Journal of Veterinary Research, 54, 195-197.